Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Asset Writedowns and Impairment (2022 - 2025)

Cosmos Health (COSM) has disclosed Asset Writedowns and Impairment for 4 consecutive years, with $18687.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Asset Writedowns and Impairment rose 23554.43% year-over-year to $18687.0, compared with a TTM value of $4.7 million through Sep 2025, down 57.48%, and an annual FY2024 reading of $4.6 million, down 60.86% over the prior year.
  • Asset Writedowns and Impairment was $18687.0 for Q2 2025 at Cosmos Health, up from -$18687.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $11.0 million in Q4 2023 and bottomed at -$31071.0 in Q1 2024.
  • Average Asset Writedowns and Impairment over 4 years is $2.0 million, with a median of $164622.0 recorded in 2023.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 117.14% in 2024, then soared 23554.43% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $5.6 million in 2022, then surged by 95.92% to $11.0 million in 2023, then crashed by 57.6% to $4.7 million in 2024, then plummeted by 99.6% to $18687.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for COSM at $18687.0 in Q2 2025, -$18687.0 in Q1 2025, and $4.7 million in Q4 2024.